COMMUNIQUÉS West-GlobeNewswire

Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
01/04/2026
WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to bringing access to great healthcare to [...]
Stryker to announce financial results for its first quarter of fiscal year 2026
01/04/2026
Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026 on Thursday, April 30, 2026. A press release will be [...]
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
01/04/2026
MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD [...]
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
01/04/2026
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics , Inc. (NASDAQ: INKT ), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore [...]
RemoniHealth Expands Hardware-Free "Vision-as-a-Service" Platform to Cover Over 90% of Chronic Eye Diseases
01/04/2026
Exclusive licensing of new breakthrough, clinic-grade tests to the RemoniHealth platform, solidifies its position as the only integrated RPM and PCM solution for population eye health NEW YORK, April 01, 2026 (GLOBE [...]
Major Shareholder Announcement
01/04/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; April 1, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Grant of share-based long-term incentive instruments to members of the Board of Management and key employees
01/04/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): According to the company’s remuneration policy adopted at the company's Annual General Meeting on 16 March 2026 and in line with the company’s usual practice, the Board of [...]
NTG Nordic Transport Group (“NTG”) announces the appointment of Carsten Trolle as CEO of its Air & Ocean division
01/04/2026
NTG is pleased to announce the appointment of Carsten Trolle as CEO of its Air & Ocean division, effective immediately. Carsten brings extensive expertise to NTG, having successfully managed and scaled multinational [...]
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
01/04/2026
Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) -- Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of AB-1002 for adults with non-ischemic cardiomyopathy and New York [...]
ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
01/04/2026
EINDHOVEN, the Netherlands, April 01, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
Your Next Dental Appointment May Save Your Life
01/04/2026
Alberta Oral Health Professionals Urge Patients to Know the Signs of Oral Cancer EDMONTON, Alberta, March 31, 2026 (GLOBE NEWSWIRE) -- When you sit down for a routine dental visit, your oral health professional is doing [...]
FibroBiologics Announces Pricing of $3 Million Public Offering
01/04/2026
HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]
Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation
01/04/2026
VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “ Company ” or “ Algernon ”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that it [...]
SpartaMax Claims Evaluated: Powerful Sparta Max Gummies for Maximum Performance Support in Men
01/04/2026
A 2026 informational overview of how the SpartaMax male enhancement gummy positions its Tongkat Ali, Ashwagandha, Maca Root, and Horny Goat Weed ingredient profile, individual dosage disclosures, formulation approach, [...]
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
01/04/2026
Lilly to gain ownership of Centessa's OX2R agonist pipeline designed to improve outcomes across sleep-wake disorders Centessa’s OX2R agonist pipeline was jointly discovered by Nxera and Centessa, and Nxera retains a [...]
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
31/03/2026
POMPANO BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue [...]
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
31/03/2026
Results from healthy volunteer study of next-generation STAT3 inhibitor, TTI-109, on track for Q2 2026 Topline data from Phase 2 trial of TTI-101 in hepatocellular carcinoma (HCC) are anticipated in H2 2026 Cash runway [...]
Arcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference
31/03/2026
WESTLAKE VILLAGE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
31/03/2026
Initiated a formal process to monetize assets Implemented a restructuring plan to significantly reduce operating expenses and extend runway SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a [...]

Pages